Upload
Featured Recent Articles Topics Login Upload

Search Results for 'Nsclc-Patients'

Nsclc-Patients published presentations and documents on DocSlides.

NSCLC with high PD-L1 expression on tumor cells or tumor-infiltrating immune cells represents disti
NSCLC with high PD-L1 expression on tumor cells or tumor-infiltrating immune cells represents disti
by sawyer742
Intervista a Federico . Cappuzzo. Background:. Pr...
SW GLH services for NSCLC – An update
SW GLH services for NSCLC – An update
by everly
Professor Rachel Butler. The genomic complexity of...
Raising the Bar in the Management of Advanced/Metastatic NSCLC
Raising the Bar in the Management of Advanced/Metastatic NSCLC
by debby-jeon
Dr Tan . Jiunn. Liang. Clinical Specialist (Resp...
Multidisciplinary approach to lung cancer
Multidisciplinary approach to lung cancer
by elena
Kamil Konopka. Department of Oncology, University ...
NSCLC: Epidemiology and disease characteristics
NSCLC: Epidemiology and disease characteristics
by scarlett
NSCLC, non-small cell lung cancer.. Lung cancer in...
The Cancer genome atlas (TCGA) and the search for a CUP genetic/epigenetic signature
The Cancer genome atlas (TCGA) and the search for a CUP genetic/epigenetic signature
by stefany-barnette
The Cancer genome atlas (TCGA) and the search for...
EGFR-Mutated NSCLC and CNS Involvement: the Conundrum
EGFR-Mutated NSCLC and CNS Involvement: the Conundrum
by pasty-toler
This program will include a discussion of off-lab...
Comparision
Comparision
by jane-oiler
of the expression of . 17-beta-hydroxysteroid . ...
NSCLC with high PD-L1 expression on tumor cells or tumor-in
NSCLC with high PD-L1 expression on tumor cells or tumor-in
by test
Intervista a Federico . Cappuzzo. Background:. P...
MEK Inhibitors and their potential role in relapsed NSCLC
MEK Inhibitors and their potential role in relapsed NSCLC
by debby-jeon
Ranee Mehra, MD. Fox Chase Cancer Center. Philade...
David R.
David R.
by alida-meadow
Gandara. , MD. University of California, Davis . ...
Striving for Consensus on the
Striving for Consensus on the
by samantha
Optimal Management of Metastatic . Non-Small Cell ...
Roberto Bianco Laboratori di Terapia Molecolare dei Tumori
Roberto Bianco Laboratori di Terapia Molecolare dei Tumori
by finley
Università . di Napoli “Federico II”. Innovat...
Istituto Toscano Tumori –Livorno, Italy
Istituto Toscano Tumori –Livorno, Italy
by payton
Federico . Cappuzzo. Istituto Toscano Tumori. Ospe...
CLINICAL EXPERIENCE OF NSCLC in RSDM
CLINICAL EXPERIENCE OF NSCLC in RSDM
by sophia
Ana Rima. PENDAHULUAN. 2. Kanker Paru. P. enyebab ...
FIRST-LINE EGFRm+ NSCLC PATIENT CASE STUDY
FIRST-LINE EGFRm+ NSCLC PATIENT CASE STUDY
by pamela
Case study 9. Provided by . Dr Qamar Ghafoor, Clin...
Updates in the systemic treatment for lung
Updates in the systemic treatment for lung
by madeline
cancer: Immunotherapy. Oscar Arrieta MD. Thoracic....
Checkpoint inhibitors for
Checkpoint inhibitors for
by paisley
NSCLC. An update. Solange Peters, MD-PhD. Oncology...
AdjuvantTherapyforStageIandIINonSmallCellLungCancerEvanCNaylorPatie
AdjuvantTherapyforStageIandIINonSmallCellLungCancerEvanCNaylorPatie
by susan2
DisclosureStatement:Theauthorhasnothingtodisclose....
NonSmallCellLungCancerVersion32022DavidSEttingerMDDouglasEWoodM
NonSmallCellLungCancerVersion32022DavidSEttingerMDDouglasEWoodM
by cecilia
NCCNCATEGORIESOFEVIDENCEANDCONSENSUSCategory1:Base...
cell lung cancer NSCLCESMO Clinical Practice Guidelines for diagnosi
cell lung cancer NSCLCESMO Clinical Practice Guidelines for diagnosi
by adia
RecommendationLoE, GoRScreening with LDCT (low-dos...
Jchem applications in Medchem
Jchem applications in Medchem
by StarsAndStripes
Prediction. . and. . Data Sorting. Zhengtao. Li...
ALL, Acute lymphoblastic leukemia;
ALL, Acute lymphoblastic leukemia;
by HappyHippo
BCMA, B-cell maturation antigen; DLBCL, diffuse la...
mRNA anticancer Vaccines
mRNA anticancer Vaccines
by byrne
breakthrough. . approach. in . cancer. . treatm...
NSCLC: Staging and TNM classification
NSCLC: Staging and TNM classification
by molly
NSCLC, non-small cell lung cancer; TNM. , tumour, ...
Presented at the European Society for Medical Oncology 2019 Barcelona
Presented at the European Society for Medical Oncology 2019 Barcelona
by lucy
– 1 October, 2019 ● GSK 3377794 activate and i...
Module 13: Targeted Treatment
Module 13: Targeted Treatment
by disclaimercanon
of Lung Cancer . Wendi S Lee, MSN, RN, NP-C. Anne ...
ASCO 2019 NSCLC - PARP & Chemotherapy
ASCO 2019 NSCLC - PARP & Chemotherapy
by mitsue-stanley
ASCO 2019 NSCLC - PARP & Chemotherapy REF Stu...
Low TPS High TPS TPS = PD-L1 tumor proportion score Low TPS = 10%; high TPS = 60%
Low TPS High TPS TPS = PD-L1 tumor proportion score Low TPS = 10%; high TPS = 60%
by olivia-moreira
Low TPS High TPS TPS = PD-L1 tumor proportion sco...
OMICS International welcomes submissions that are original and technically so as to serve both th
OMICS International welcomes submissions that are original and technically so as to serve both th
by lois-ondreau
OMICS Journals are poised in excellence by publi...
Estimated costs of managing treatment-related adverse
Estimated costs of managing treatment-related adverse
by lindy-dunigan
eventsof. . nivolumab. and . docetaxel. in the...
L’algoritmo terapeutico
L’algoritmo terapeutico
by calandra-battersby
attraverso . i . c. asi clinici. Giuseppe . Valma...
Slides last updated:
Slides last updated:
by stefany-barnette
October 2013 . Ferlay . J, Shin HR, Bray F, Forma...
Slides last updated:
Slides last updated:
by calandra-battersby
October 2013. There are two main types of lung . ...
Lung malignancy
Lung malignancy
by tawny-fly
Dr. Rachel Cary, FY1 Warwick Hospital. Learning ...